Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acelrx Pharmaceuticals (DE:R5X)
FRANKFURT:R5X
Acelrx (R5X) Financial Statements
0 Followers
Acelrx Financial Overview
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 570.00K | $ 442.00K | $ 2.00K | $ 1.86M | $ 443.00K |
| Gross Profit | $ -306.00K | $ -342.00K | $ -1.23M | $ 1.42M | $ -597.00K |
| EBIT | $ 70.99M | $ -8.28M | $ -7.45M | $ -7.84M | $ -9.22M |
| EBITDA | $ 71.45M | $ -7.86M | $ -6.99M | $ -7.35M | $ -8.64M |
| Net Income Common Stockholders | $ 70.66M | $ -8.67M | $ -7.92M | $ -8.38M | $ -9.85M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 22.92M | $ 39.35M | $ 51.63M | $ 48.70M | $ 55.33M |
| Total Assets | $ 56.13M | $ 71.97M | $ 77.89M | $ 72.26M | $ 79.59M |
| Total Debt | $ 14.39M | $ 16.62M | $ 18.62M | $ 20.40M | $ 22.76M |
| Net Debt | $ -8.54M | $ -22.73M | $ -33.01M | $ -28.30M | $ -32.57M |
| Total Liabilities | $ 22.99M | $ 110.24M | $ 113.79M | $ 115.28M | $ 115.58M |
| Stockholders Equity | $ 33.14M | $ -38.27M | $ -35.89M | $ -43.02M | $ -35.99M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -8.81M | $ -9.02M | $ -8.03M | $ -4.13M | $ -9.94M |
| Operating Cash Flow | $ -8.75M | $ -8.93M | $ -8.00M | $ -3.94M | $ -8.35M |
| Investing Cash Flow | $ 9.17M | $ 20.18M | $ -4.44M | $ -6.65M | $ 2.39M |
| Financing Cash Flow | $ -2.08M | $ -2.08M | $ 11.84M | $ -2.46M | $ -2.08M |
Acelrx Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.